AirSculpt Technologies, Inc. - Common Stock (AIRS)
2.6250
-2.3850 (-47.60%)
NASDAQ· Last Trade: Aug 10th, 1:12 PM EDT
Detailed Quote
Previous Close
5.010
Open
2.865
Bid
2.620
Ask
2.630
Day's Range
2.500 - 3.120
52 Week Range
1.510 - 12.00
Volume
2,936,052
Market Cap
146.06M
PE Ratio (TTM)
-9.375
EPS (TTM)
-0.3
Dividend & Yield
N/A (N/A)
1 Month Average Volume
399,832
Chart
About AirSculpt Technologies, Inc. - Common Stock (AIRS)
Airsculpt Technologies Inc is a pioneering company specializing in minimally invasive body contouring procedures. The company has developed a unique technique that aims to provide patients with a more refined and effective option for fat removal and body sculpting, distinguishing itself in the competitive aesthetic market. Through a proprietary approach that emphasizes precision and safety, Airsculpt Technologies focuses on enhancing patient satisfaction and outcomes while advancing the field of cosmetic surgery. With a commitment to innovation and quality care, the company seeks to redefine body aesthetics for its clientele. Read More
AirSculpt Technologies (NASDAQ:AIRS) reported second-quarter revenue of $42.9 million, down 2.5% from the prior-year period, as the company cited stable revenue trends, positive same-center case growth and continued investment in marketing and expanded procedure offerings.
Chief Executive Officer Y
MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences.
AirSculpt Technologies (NASDAQ:AIRS) executives said the body contouring company has returned to same-store sales growth after more than two years of declines, while outlining plans to expand services tied to GLP-1 weight-loss drug side effects and eventually resume clinic growth across the U.S.
Ch
AirSculpt Technologies (NASDAQ:AIRS) reported first-quarter fiscal 2026 results that management characterized as a “key turning point,” citing stabilized revenue, the first positive same-center sales result in more than two years, and continued debt reduction.
Q1 results: flat revenue, positive sam
MIAMI BEACH, Fla., April 06, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 2nd, 2026, by AirSculpt Technologies, Inc. (NASDAQ:AIRS), please note that the Company determined that a one-time non-cash adjustment related to the closure of its London facility was inaccurate in the calculation of Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Net (Loss)/Income. The updated release reflects the updated figures.
MIAMI BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2025.
MIAMI BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report fourth quarter and fiscal year 2025 financial results before market open on Thursday, April 2, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time.
MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the appointment of Mike Doyle as the Non-Executive Chairman of its Board of Directors.
New York, NY – November 10, 2025 – AirSculpt Technologies (NASDAQ: AIRS), a prominent player in the body contouring and fat removal market, saw its shares plummet by over 41% on November 7, 2025, in a dramatic market reaction to its deeply disappointing third-quarter fiscal 2025 earnings report. The precipitous decline sent
